Reevaluating current models of thymic involution.
Level 5 - mechanism / opinion, no new human data
Narrative review and conceptual re-evaluation without primary clinical data or systematic synthesis.
PubMed 15967677 · doi:10.1016/j.smim.2005.05.006
What was done
The author performed a narrative re-evaluation of traditional models of thymic involution—specifically the concept that involution starts or accelerates primarily at puberty due to rising sex steroids and falling growth hormone levels blocking immature intrathymic progenitors—and reviewed newer data challenging this paradigm.
What was found
The abstract presents no quantitative data or specific numerical endpoints. It summarizes conceptual findings indicating that foundational assumptions behind endocrine-driven thymic involution models are being questioned and require revision based on newer experimental findings.
Why it matters
Understanding the precise drivers and timeline of thymic involution is central to developing strategies for immune reconstitution in aging, cancer therapy, and immunodeficiency.
Limits
The abstract describes a narrative review without reported systematic search methods, sample sizes, or quantitative data, limiting objective verification of the summarized claims from the abstract alone.
Cited by
- supports The human thymus grows from birth until puberty under the influence of hormones like melatonin, growth hormone, and DHEA, and undergoes involution after puberty.